Subscribe to ExpertReview

The latest research, meeting updates and CME, in your inbox.

Hong Kong · Sponsored

HK Ocular Surface Newsletter Issue No. 3 Jul 2023

24 Jul 2023Ophthalmology

Connie TANG

Share

This content is sponsored. It is intended for healthcare professionals only.

Haematopoietic stem cell transplantation (HSCT) remains to be the last hope of survival for many haematological malignancies and non-malignant disorders.

MPR-SAN-2022174 Case sharing_website_icon issue 3

For healthcare professionals

This sponsored content is for registered Hong Kong doctors. Log in or register to read it. If you received an access link, open it from your email.

Log inRegister

Related posts

Stylized illustration of a large blue immune cell with surface receptors and yellow nuclei, surrounded by smaller cells.Research · OncologyESCAT v2 adds graded certainty tiers and a resistance scale for molecular targetsAn international ESMO expert panel has revised the 2018 ESCAT framework, restructuring Tier I, Tier II and Tier X, formalising tumour-agnostic gating criteria and adding a four-level scale for resistance biomarkers.8 Nov 2026